Phytoceuticals' portfolio consists of three different promising product candidates:
1 PRIMARY WOUND DRESSING® is Phytoceuticals' novel primary wound dressing for acute and chronic human wounds.
In addition, Phytoceuticals will launch a novel wound spray for veterinary wounds (PHY020) in 2011 and has initiated proof-of-concept phase for PHY030, a potentially powerful product for human inflammatory skin disorders.
